The implication, some say, is that when TAVI expanded to lower-risk patients in 2019, death rates rose—not so fast, say others.
MedPage Today on MSN
Aortic stenosis mortality increased after broad FDA approval of TAVR
Delays in diagnosis, long waits for operations may explain trend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results